Cancer Center Administration

癌症中心管理

基本信息

批准号：
10400642
负责人：
Sharon Gail Levy
金额：
$ 19.54万
依托单位：
GEORGETOWN UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
起止时间：
1997-08-15 至 2024-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10400642
关键词：
Academic Medical Centers Applications Grants Appointment Basic Science Benchmarking Budgets Cancer Center Cancer Center Support Grant Capital Clinical Clinical Cancer Center Clinical Data Clinical Protocols Clinical Research Clinical Trials Collaborations Communication Community Outreach Comprehensive Cancer Center Contracts Data Direct Costs Education and Outreach Enrollment Ensure Environment Equipment Evaluation Faculty Fostering Funding Future Grant Guidelines Head Health Human Resources Individual Information Systems Intervention Trial Investments Joints Knowledge Leadership Link Measurement Meridians Methods Mission Monitor National Cancer Institute New Jersey Office Management Operations Research Peer Review Policies Population Research Process Productivity Protocols documentation Publications Reporting Research Research Infrastructure Research Personnel Research Project Grants Research Support Resource Sharing Resources Safety Strategic Planning System Talents Training and Education Translational Research Universities Vision Washington anticancer research base cancer education equipment acquisition experience meetings member peer programs recruit tool

项目摘要

ABSTRACT The mission of the Lombardi Comprehensive Cancer Center (LCCC) Consortium’s Administration is to facilitate and implement LCCC’s vision and create, support and sustain an environment that fosters research, interactivity and optimal productivity of Cancer Center investigators and adds value to the Center. The LCCC Consortium is comprised of Georgetown Lombardi Comprehensive Cancer Center, based in Washington, DC (LCCC-DC) and the John Theurer Cancer Center (JTCC) of Hackensack Meridian Health (HMH), based in Hackensack, NJ (LCCC-NJ). Supporting four Research Programs, nine Shared Resources and 114 members focused on basic, translational, clinical and population-based research, the Administration oversees $13.57M ($11.98M LCCC-DC, $1.58M LCCC-NJ) ADC in peer-reviewed funding and $23.1M ($21.4M LCCC-DC, $1.7M LCCC-NJ) in other grants and contracts (direct costs). Michael Vander Hoek, MHSA, Associate Director (AD) for Administration, heads the administrative team, supporting LCCC leadership planning, strategic investments, benchmarking, evaluation and communication with constituencies. In addition to building an experienced management team to support Cancer Center members, Vander Hoek managed the recruitment of numerous investigators and supported their faculty appointments and promotions. He and his team have successfully managed institutional commitments to support these strategic initiatives. The Administration tracks and manages LCCC’s $216.9M in institutional investments from Georgetown University Medical Center (GUMC), MedStar Health (MH) and HMH, ensuring that investments are linked to LCCC’s strategic plan. The Administration documents and executes LCCC’s policies on membership, pilot funding, equipment purchases, Shared Resources and space. The Administration also coordinates cancer research education and training. Significant expansion of administrative activities has supported an increasingly productive relationship with MH, as a clinical partner, and JTCC, which is LCCC’s clinical campus in New Jersey, aimed at increasing accrual to interventional trials and increasing the diversity of individuals enrolling in trials. For example, the Administration led the implementation of the OnCore enterprise-wide Clinical Trial Management System (CTMS). Other activities are highlighted in the narrative.

抽象的隆巴迪综合癌症中心 (LCCC) 联盟管理机构的使命是促进实现 LCCC 的愿景，创建、支持和维持一个促进研究、互动的环境和癌症中心研究人员的最佳生产力，并为该中心增加价值。由位于华盛顿特区的乔治城隆巴迪综合癌症中心 (LCCC-DC) 和位于新泽西州哈肯萨克的 Hackensack Meridian Health (HMH) 的 John Theurer 癌症中心 (JTCC) (LCCC-NJ) 支持四个研究项目、九个共享资源和 114 名成员，重点关注基础、转化、临床和人群研究，政府监管 1,357 万美元（LCCC-DC、1,198 万美元） 158 万美元 LCCC-NJ) ADC 同行评审资金和 2310 万美元（2140 万美元 LCCC-DC，170 万美元 LCCC-NJ）其他资金赠款和合同（直接费用） Michael Vander Hoek，MHSA，行政副主任（AD），领导管理团队，支持 LCCC 领导规划、战略投资、基准测试、除了建立经验丰富的管理团队之外，还需要与选民进行评估和沟通。为了支持癌症中心成员，Vander Hoek 负责招募众多研究人员并支持他们的教员任命和晋升他和他的团队成功地管理了机构。政府跟踪和管理 LCCC 的 2.169 亿美元资金。来自乔治城大学医学中心 (GUMC)、MedStar Health (MH) 和 HMH 的机构投资，确保投资与 LCCC 的战略计划挂钩。 LCCC 关于会员资格、试点资金、设备采购、共享资源和空间的政策。行政部门还协调癌症研究教育和培训。活动支持了与作为临床合作伙伴的 MH 和 JTCC 日益富有成效的关系，是 LCCC 位于新泽西州的临床园区，旨在增加介入试验的收益并增加例如，政府主导了 OnCore 的实施。叙述中还重点介绍了企业范围的临床试验管理系统 (CTMS)。